Med One Capital and Signostics joined forces to provide customized financial options to clinicians for Signostics’ latest portable ultrasound technology.

In early May, Signostics launched its newest technology at the American Urological Association meeting. When attendees indicated an immediate need for financing it brought the two companies together, allowing acute care and private practices to move forward rapidly with this portable ultrasound technology.

“We look forward to working with the Signostics team to provide our 25-plus years of experience financing medical technologies for healthcare providers,” said Robb Stevens, SVP of Leasing Sales at Med One Capital. “We recognize the value of this new technology and believe that together we can provide a simple and easy solution for any customer to acquire it.”

“We recognized that many customers would see immediate value in USCAN but would need help in finding the budget,” said Signostics VP of Sales, Ryan Detzel. “Med One Capital was our number one choice based on their knowledge of our customers’ needs and their reputation for being committed to helping healthcare providers access new technology, as well as their simple and easy to understand process.”